About Shruti Drugs
Shruti Drugs is a Technology company based in Secunderabad (India) founded in 1992. It provides web-based email access, mailbox administration, and device synchronization tools. It operates on a SaaS and B2B model. Its Indian entity Shruti Drugs Private Limited reported revenue of ₹39.47 Cr. Shruti Drugs offers products and services including WebMail Client, Web Administration Portal, Exchange ActiveSync, Mobile Calendaring (CalDAV), and Mobile Contacts (CardDAV). Its focus areas include Information Technology, Email Services, Collaboration and Mobile Synchronization. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
MailEnable is a software service that enables users to access and manage email mailboxes through web browsers on desktops and mobile devices. It supports features like ActiveSync for mobile synchronization, CalDAV for calendaring, CardDAV for contacts, and ICS sharing for calendar access. The platform allows users to administer mailboxes and synchronize contacts, calendars, and tasks via HTTP requests, catering to individuals and businesses without specified locations or clients.
- Headquarters Secunderabad, India
- SectorsTechnology
- Website shrutidrugs.com
- Legal Name Shruti Drugs Private Limited
- Date of Incorporation 11 Jul, 1994
- Jurisdiction Secunderabad, Telangana, India
- Annual Revenue₹39.47 Cr
FY 2025 · +35% YoY
- Net Profit₹78.1 Lakh
FY 2025 · 2% margin
- EBITDA₹2.94 Cr
FY 2025 · 7% margin
Associated legal entities of Shruti Drugs
Shruti Drugs operates through Shruti Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shruti Drugs Private Limited CIN U24230TG1994PTC017903 | Active | 11 Jul 1994 | Secunderabad, Telangana | ₹39.5 Cr | 2 | View details |
Products & Services of Shruti Drugs
Shruti Drugs offers a comprehensive portfolio of products and services, including WebMail Client, Web Administration Portal, Exchange ActiveSync, Mobile Calendaring (CalDAV), and Mobile Contacts (CardDAV).
Enables mailbox access via desktop and mobile web browsers.
Allows creation and management of mailboxes through web browsers.
Supports ActiveSync protocol for mobile device email access.
Facilitates remote access to mailbox calendars on devices.
Enables remote access and synchronization of mailbox contacts.
Allows sharing and access to public calendar files via HTTP.
Provides integration for Microsoft Outlook on desktops.
Synchronizes contacts, calendars, and tasks with MailEnable accounts.
Board of directors of Shruti Drugs Private Limited (Shruti Drugs)
Shruti Drugs Private Limited is the primary company behind Shruti Drugs. The board of Shruti Drugs Private Limited currently have 2 directors; the longest-serving is Prakash Praveen Chandra Kadakia, appointed in 1994. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Prakash Praveen Chandra Kadakia DIN 01632870 | Director | 24 Jul 1994 | 32 yrs 3 mo | Shruti Drugs Private Limited |
| Nishit Prakash Chandra Kadakia DIN 01632866 | Director | 29 Jul 1994 | 32 yrs 3 mo | Shruti Drugs Private Limited |
Financials of Shruti Drugs
Figures of Shruti Drugs Private Limited, the primary company behind Shruti Drugs, for FY 2025. Revenue was ₹39.47 Cr (+35% year on year). Net profit was ₹78.1 Lakh (2% margin). EBITDA was ₹2.94 Cr (7% margin). Revenue has grown at a compounded annual rate of +15% over three years and -9% over five years.
- ₹39.47 CrRevenue · FY 2025 · +35% YoY
- ₹78.1 LakhNet profit · 2% margin
- ₹2.94 CrEBITDA · 7% margin
- ₹1.86 CrPaid-up capital
- +15%Revenue CAGR, 3 years
- -9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Shruti Drugs Private Limited are on its company page.
Detailed financial statements for Shruti Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Shruti Drugs
Shruti Drugs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Shruti Drugs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shruti Drugs
Shruti Drugs was founded in 1992.
Shruti Drugs is headquartered in Secunderabad, India. It is registered at Secunderabad, Telangana, India.
The primary company behind Shruti Drugs, Shruti Drugs Private Limited, reported revenue of ₹39.47 Cr for FY 2025, up 35% year on year.
MailEnable is a software service that enables users to access and manage email mailboxes through web browsers on desktops and mobile devices. It supports features like ActiveSync for mobile synchronization, CalDAV for calendaring, CardDAV for contacts, and ICS sharing for calendar access. The platform allows users to administer mailboxes and synchronize contacts, calendars, and tasks via HTTP requests, catering to individuals and businesses without specified locations or clients.
Shruti Drugs's top competitors include Laurus Labs, Symbiotec and SeQuent.
Shruti Drugs offers WebMail Client, Web Administration Portal, Exchange ActiveSync, Mobile Calendaring (CalDAV), and 4 more products and services.
Shruti Drugs operates through Shruti Drugs Private Limited.
The legal entities of Shruti Drugs currently have 2 directors, including Prakash Praveen Chandra Kadakia, Nishit Prakash Chandra Kadakia.